Effect of smartphone apps on glycemic control in young patients with type 1 diabetes : A meta-analysis

Copyright © 2023 Pi, Shi, Wang and Zhou..

Objectives: Achieving glycemic control is a great challenge for young patients with type 1 diabetes (T1D), especially during the transition from childhood to adulthood. As various smartphone apps have been developed to improve glycemic control in T1D, we performed a meta-analysis of randomized controlled trials to assess the effect of smartphone apps on glycemic control in young patients with T1D.

Methods: We systematically searched PubMed, Embase, and the Cochrane Library for randomized controlled trials comparing combined usual care and smartphone app treatment to usual care alone. This meta-analysis is reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement. The primary outcomes were the weighted difference in means (WMD) of HbA1c change from baseline and the person-years incidence of mild hypoglycemia or severe hypoglycemia between intervention and control groups. We assessed pooled data by use of a random-effects model.

Results: Of 1,190 identified studies, nine were eligible and included in our analysis (N = 748 participants). Relative to the control, using smartphone apps yielded a non-significant reduction in glycated hemoglobin (HbA1c) (WMD = -0.26, 95% CI: -0.56 to 0.05; p = 0.10) and no increased frequency of mild hypoglycemia (WMD = 1.87, 95% CI: -1.52 to 5.27; p = 0.49) or severe hypoglycemia (WMD = -0.04, 95% CI: -0.35 to 0.27; p = 0.80). In further subgroup analysis, compared with the recording-style app group, the auxiliary-style app group exhibited a significant reduction in HbA1c (WMD = -0.83, 95% CI: -1.10 to -0.56, p < 0.001).

Conclusion: The current pooled data analysis did not reveal a significant reduction in HbA1c in young patients with T1D undergoing treatment with smartphone apps and usual care in combination. However, auxiliary-style apps with insulin or carbo calculators were beneficial in reducing HbA1c.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Frontiers in public health - 11(2023) vom: 15., Seite 1074946

Sprache:

Englisch

Beteiligte Personen:

Pi, Linhua [VerfasserIn]
Shi, Xiajie [VerfasserIn]
Wang, Zhen [VerfasserIn]
Zhou, Zhiguang [VerfasserIn]

Links:

Volltext

Themen:

Blood Glucose
Glycated Hemoglobin
Glycemic control
Hypoglycemia
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Smartphone apps
Type 1 diabetes
Young patients

Anmerkungen:

Date Completed 19.04.2023

Date Revised 25.04.2023

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.3389/fpubh.2023.1074946

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM35568750X